The 13th Annual Meeting of the Asian Organization for Crohn’s and Colitis（AOCC2025）

Dana Verbovsky, Andres J Yarur¹, Geert R D'Haens², Filip Baert³, Martina Goetsch⁴, Chuanbo Zang⁵, Guibao Gu⁶, Rafal Mazur⁴, Michael Keating⁷, Elizabeth Kudlacz⁸, Sarah Sidhu⁷, *Karolina Wosik⁹, Silvio Danese¹⁰ (1. Inflammatory Bowel Disease Center and Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA, 2. Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands, 3. Department of Gastroenterology, AZ Delta, Roeselare, Belgium, 4. Pfizer AG, Zürich, Switzerland, 5. Pfizer Inc, Collegeville, PA, USA, 6. Pfizer Inc, La Jolla, CA, USA, 7. Pfizer Inc, New York, NY, USA, 8. Pfizer Inc, Groton, CT, USA, 9. Pfizer Canada, Kirkland, QC, Canada, 10. Division of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita Salute San Raffaele University, Milan, Italy)

Dana Verbovsky, Séverine Vermeire¹, David T Rubin², Miguel D Regueiro³, *Ken Takeuchi⁴, Alissa Walsh⁵, Paulo G Kotze⁶, Aline Charabaty⁷, Martina Goetsch⁸, Krisztina Lazin⁸, Joseph Wu⁹, Georgios Tsamos¹⁰, Michelle Segovia¹¹, Diogo Branquinho¹¹, Silvio Danese¹² (1. Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium, 2. University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA, 3. Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH, USA, 4. Department of Gastroenterology, IBD Centre, Tsujinaka Hospital Kashiwanoha, Kashiwa, Chiba, Japan, 5. Translational Gastroenterology Unit, Oxford University Hospital, Oxford, UK, 6. IBD Outpatient Clinics, Colorectal Surgery Unit, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Brazil, 7. Division of Gastroenterology and Hepatology, Johns Hopkins School of Medicine, Washington, DC, USA, 8. Pfizer AG, Zürich, Switzerland, 9. Pfizer Inc, Cambridge, MA, USA, 10. Pfizer, Thessaloniki, Central Macedonia, Greece, 11. Pfizer Inc, New York, NY, USA, 12. Division of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita Salute San Raffaele University, Milan, Italy)

Dana Verbovsky, Krisztina B Gecse¹, María Chaparro², Maria T Abreu³, Yvette Leung⁴, Elena Sonnenberg⁵, Aoibhinn McDonnell⁶, Krisztina Lazin⁷, Joseph Wu⁸, Christina C Smith⁹, Márjori Dulcine¹⁰, *Karolina Wosik¹¹ (1. Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands, 2. Department of Gastroenterology, Hospital Universitario de La Princesa, IIS Princesa, UAM, CIBERehd, Madrid, Spain, 3. F. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai, Los Angeles, CA, USA, 4. Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 5. Medizinische Klinik m. S. Gastroenterologie, Infektiologie und Rheumatologie, Charité-Universitätsmedizin Berlin, Berlin, Germany, 6. Pfizer Ltd, Sandwich, UK, 7. Pfizer AG, Zürich, Switzerland, 8. Pfizer Inc, Cambridge, MA, USA, 9. Pfizer Inc, Collegeville, PA, USA, 10. Pfizer Brazil, São Paulo, Brazil, 11. Pfizer Canada, Kirkland, QC, Canada)

Dana Verbovsky, Britta Siegmund^1,2, Rathi D Ryan³, Catherine M Crosby⁴, Maria T Abreu⁵, Séverine Vermeire⁶, Iris Dotan^7,8, Keren M Rabinowitz^7,9, Xiang Guo¹⁰, H Kiyomi Komori¹¹, Martina Goetsch¹², *Karolina Wosik¹³, John C Woolcott¹⁰, Silvio Danese¹⁴ (1. Med. Klinik für Gastroenterologie, Infektiologie, Rheumatologie, Charité – Universitätsmedizin Berlin, Berlin, Germany, 2. Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Benjamin Franklin, Berlin, Germany, 3. Pfizer Inc, San Francisco, CA, USA, 4. Pfizer Inc, La Jolla, San Diego, CA, USA, 5. F. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai, Los Angeles, CA, USA, 6. Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium, 7. Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel, 8. Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel, 9. Felsentstein Medical Research Centre, Medical and Health Sciences, Tel Aviv, Israel, 10. Pfizer Inc, Collegeville, PA, USA, 11. Formerly Arena Pharmaceuticals, San Diego, CA, USA; a wholly-owned subsidiary of Pfizer Inc, New York, NY, USA, 12. Pfizer AG, Zürich, Switzerland, 13. Pfizer Canada, Kirkland, QC, Canada, 14. Division of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita Salute San Raffaele University, Milan, Italy)

*Hiroshi Nakase¹, David T. Rubin², Silvio Danese³, Peter Irving⁴, Douglas C. Wolf⁵, Preetika Sinh⁶, Bruce A. C. Cree⁷, Olga Alekseeva⁸, Fred D. Lublin⁹, Norma Ruiz Santiago¹⁰, Zhaohui Liu¹⁰, AnnKatrin Petersen¹⁰, Dimpy Mehra¹⁰, Anjali Jain¹⁰, Anthony Krakovich¹⁰, Chun-Yen Cheng¹⁰, Jon V. Riolo¹⁰, Erik DeBoer¹⁰, Jeffrey A. Cohen¹¹, Ryan C. Ungaro⁹ (1. Sapporo Medical University, Sapporo, Japan, 2. University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA, 3. Department of Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy, 4. Guy’s and St Thomas’ NHS Foundation Trust, London, UK, 5. Center for Crohn’s Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, GA, USA, 6. Division of Gastroenterology, Medical College of Wisconsin, Milwaukee, WI, USA, 7. Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA, 8. Department of Gastroenterology, Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod, Russia, 9. Icahn School of Medicine at Mount Sinai, New York, NY, USA, 10. Bristol Myers Squibb, Princeton, NJ, USA, 11. Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA)

*Taku Kobayashi¹, Joana Torres², Randy Longman³, Konstantinos Katsanos⁴, Scott Lee⁵, Dominik Bettenworth⁶, Louis Korman⁷, Dimpy Mehra⁸, Norma Ruiz Santiago⁸, AnnKatrin Petersen⁸, Manik Desai⁸, Hsiuanlin Wu⁸, Dong Wang⁹, Mark T. Osterman⁸, Anjali Jain⁸, Bincy P. Abraham¹⁰ (1. Kitasato University Kitasato Institute Hospital, Tokyo, Japan, 2. Division of Gastroenterology, Hospital da Luz and Hospital Beatriz Angelo, Lisbon, Portugal; and Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal, 3. Weill Cornell Medicine, New York, NY, USA, 4. Division of Gastroenterology, University of Ioannina, Ioannina, Greece, 5. Digestive Health Center, University of Washington Medical Center, Seattle, WA, USA, 6. University of Münster, Münster, Germany; and CED Schwerpunktpraxis, Münster, Germany, 7. Capital Digestive Care, Washington, DC, USA, 8. Bristol Myers Squibb, Princeton, NJ, USA, 9. Bristol Myers Squibb K. K., Tokyo, Japan, 10. Houston Methodist-Weill Cornell, Houston, TX, USA)

*Silvio Danese¹, Raymond K. Cross², Douglas C. Wolf³, Katsuyoshi Matsuoka⁴, Iris Dotan⁵, Brigid S. Boland⁶, Laura E. Raffals⁷, Dimpy Mehra⁸, Norma Ruiz Santiago⁸, AnnKatrin Petersen⁸, Manik Desai⁸, Hsiuanlin Wu⁸, Dong Wang⁹, Mark T. Osterman⁸, Anjali Jain⁸, James O. Lindsay¹⁰ (1. Department of Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy, 2. Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy Medical Center, Baltimore, MD, USA, 3. Center for Crohn’s Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, GA, USA, 4. Toho University Sakura Medical Center, Sakura, Chiba, Japan, 5. The Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel, 6. Department of Medicine, University of California San Diego, La Jolla, CA, USA, 7. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA, 8. Bristol Myers Squibb, Princeton, NJ, USA, 9. Bristol Myers Squibb K. K., Tokyo, Japan, 10. Barts and the London School of Medicine and Dentistry, London, UK)

*TADAKAZU HISAMATSU¹, Hiroshi Nakase², Katsuyoshi Matsuoka³, Masayuki Saruta⁴, Taku Kobayashi⁵, Takahiro Katayama⁶, Kazuhiro Toriyama⁶, Dong Wang⁶, Yoko Uchikawa⁶, Anjali Jain⁷, Angela Ren⁷, Toshifumi Hibi⁵ (1. Kyorin University School of Medicine, Tokyo, Japan, 2. Sapporo Medical University, Sapporo, Japan, 3. Toho University Sakura Medical Center, Chiba, Japan, 4. Jikei Medical University, Tokyo, Japan, 5. Kitasato University Kitasato Institute Hospital, Tokyo, Japan, 6. Bristol Myers Squibb K. K., Tokyo, Japan, 7. Bristol Myers Squibb, Princeton, NJ, USA)

*Tadakazu Hisamatsu¹, Ken Takeuchi², Qian Cao³, Keiji Ozeki⁴, Sang-Bum Kang⁵, Jen-Wei Chou⁶, Madhuja Mallick⁷, Tomoko Matsuda⁸, Pierre A Morisset⁷, Jasmina Kalabic⁹, Yuji Ogawa⁸, Yafei Zhang⁷, Yuh-Ying Yeh⁷ (1. Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, 2. Department of Gastroenterology, IBD Centre, Tsujinaka Hospital Kashiwanoha, 3. Department of Gastroenterology and Inflammatory Bowel Disease Center, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 4. Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 5. Department of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 6. Center for Digestive Disease, Department of Internal Medicine, China Medical University Hospital, 7. AbbVie Inc., 8. AbbVie GK, 9. AbbVie Deutschland GmbH & Co. KG)

*Shinji Ota¹, Taka Asari¹, Yohei Sawada¹, Kyoko Amenomori¹, Tetsuya Tatsuta¹, Keisuke Hasui¹, Hidezumi Kikuchi¹, Hiroto Hiraga¹, Daisuke Chinda¹, Hirotake Sakuraba¹ (1. Department of Gastroenterology, Hematology and Clinical immunology, Hirosaki University Graduate School of Medicine)

*Jingwen Liu¹, Wen Hu², Shuyan Li¹, Shurong Hu¹, Yan Chen¹ (1. the Second Affiliated Hospital of Zhejiang University School of Medicine, 2. the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine))